Skip to main navigation Skip to search Skip to main content

PTEN expression in diffuse large B-cell lymphomas

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Diffuse large B-cell lymphomas (DLBCL) constitute the largest subgroup of non-Hodgkin lymphomas (NHL) in adults. Although the etiology of NHL is not fully understood, different genetic abnormalities, involving particularly oncogenes, were shown as a mechanism of lymphomagenesis. Mutations of tumor suppressor genes, unlike oncogenes, have been relatively less studied in DLBCL. PTEN, a tumor suppressor gene located at 10q23, has been shown to be mutated or deleted in a variety of solid tumors. In this study, loss of PTEN expression was evaluated immunohistochemically in 102 patients with DLBCL. Partial or complete loss of PTEN was detected in about one-third of the cases, leading to the conclusion that it might contribute to the lymphomagenesis in some cases.
Original languageEnglish
Title of host publicationProceedings Of The Xvii Meeting International Society Of Haematology (european And African Division)
EditorsW Linkesch
PublisherMedimond S R L
Pages125-131
Number of pages7
ISBN (Print)88-323-3147-0
Publication statusPublished - 2003
Event17th European and African Division Meeting of the International-Society-of-Haematology - GRAZ, Austria
Duration: 7 Sept 200310 Sept 2003

Conference

Conference17th European and African Division Meeting of the International-Society-of-Haematology
Country/TerritoryAustria
CityGRAZ
Period7/09/0310/09/03

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Tumor-suppressor
  • 3-kinase/akt pathway
  • Germline mutations
  • Pten/mmac1
  • Gene
  • Phosphatase
  • Breast
  • Cancer

Fingerprint

Dive into the research topics of 'PTEN expression in diffuse large B-cell lymphomas'. Together they form a unique fingerprint.

Cite this